Here are three key notes:
1. The company’s common stock began trading under the symbol “XTNT” on Oct. 19.
2. Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets.
3. Xtant Medical recently participated in the North American Spine Society annual meeting in October and showcased its X-spine and Bacterin product portfolios at the meeting.
More articles on devices:
Soft Tissue Regeneration launches L-C Ligament clinical trial — 5 takeaways
Dr. Charles Brooker implants permanent spinal cord stimulator in Australia: 5 things to know
InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
